More recently, it was shown that an antibody against the extracellular PTPRZ1 domain in GBM stem cells inhibits PTN binding and thus suppresses GBM growth in mice, leading to prolonged survival [48]. This evidence concerns the gene PTPRZ1 and glioblastoma.